Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2009

01-04-2009 | Research Articles

Screening practice and misplaced priorities

Authors: Davide Mauri, Antonis Valachis, Nikolaos P. Polyzos, Ivan Cortinovis, Vassiliki Karampoiki, Evridiki Loukidou, Paraskevi Alevizaki, Konstantinos Kamposioras, Georgios Kouris, Parthenopi Alexandropoulou, Lamprini Tsali, Charalampos Panou, Athanasios Stamatelopoulos, Velisarios Lakiotis, Anastasia Spiliopoulou, Aikaterini Terzoudi, Aliki Ioakimidou, Ioanna Karathanasi, Magdalini Bristianou, Giovanni Casazza, Nicholas Pavlidis

Published in: Clinical and Translational Oncology | Issue 4/2009

Login to get access
Metadata
Title
Screening practice and misplaced priorities
Authors
Davide Mauri
Antonis Valachis
Nikolaos P. Polyzos
Ivan Cortinovis
Vassiliki Karampoiki
Evridiki Loukidou
Paraskevi Alevizaki
Konstantinos Kamposioras
Georgios Kouris
Parthenopi Alexandropoulou
Lamprini Tsali
Charalampos Panou
Athanasios Stamatelopoulos
Velisarios Lakiotis
Anastasia Spiliopoulou
Aikaterini Terzoudi
Aliki Ioakimidou
Ioanna Karathanasi
Magdalini Bristianou
Giovanni Casazza
Nicholas Pavlidis
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0345-7

Other articles of this Issue 4/2009

Clinical and Translational Oncology 4/2009 Go to the issue

Reviews

Pralatrexate, a new hope for aggressive T-cell lymphomas?

News and Views

Vegetal memory

Research Articles

The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32

Research Articles

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Educational Series

Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis

Educational Series

Hedgehog signalling as a target in cancer stem cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits